When Williams and Kane' administered inhaled isoprenaline to asthmatic patients by a noncumulative technique, they found that the response reached a plateau after the 20 ,ug dose. In contrast, Shenfield and Paterson,2 using a cumulative technique to administer ,B agonists, found a dose related increase in FEV, and a linear log dose-response relationship. Williams and Kane' suggested that the increasing response with increasing doses with the cumulative technique might be due to increased penetration of sequential doses of inhaled drug after the bronchodilatation caused by early doses. Since there has been no 
Results
Mean baseline values of FEV, for the 10 subjects ranged from 0-49 to 2-08 (21-60% predicted). The maximum percentage change in FEV, from baseline after isoprenaline ranged from 30% to 178%.
Mean baseline values for the cumulative doseresponse studies were 1-18 and 2-29 for FEV, and FVC and 210 1 min-' for PEFR. These did not differ from the mean baseline values on the four noncumulative study days.
Mean values for the change in FEV,, FVC, and PEFR are shown in the figure. The area under the cumulative FEV, dose-response curve was greater than that under the non-cumulative curve (p < 005). There was no significant difference between the cumulative and non-cumulative studies for FVC or PEFR. Analysis of the percentage rather than absolute change in the three measurements produced similar curves and identical levels of significance between the two studies.
Discussion
This is the first direct comparison of cumulative and non-cumulative dose-response curves for the same subjects. Doses of isoprenaline were given at five minute intervals since the response to inhaled isoprenaline is near maximum at this time and a longer time would have rendered earlier doses inactive by the end of the study. 3 The response was greater with the cumulative technique than the non-cumulative technique for FEVy, FVC, and PEFR, though the differences were significant only for FEVy. Since the magnitude of the difference between the two techniques was similar for FEVI, FVC, and PEFR-15%, 9%, and 16% respectively-differences in statistical significance presumably reflect the relatively small differences between the two techniques and the better reproducibility of FEV1 measurements.
FEVI and FVC increased with log dose isoprenaline in both the cumulative and the noncumulative studies. Although there was no significant difference between the PEFR doseresponse curves for the two techniques the response 
